Australian Clinical Labs Ltd (ACL)

Sydney
3.72
-0.10(-2.62%)
  • Volume:
    921,024
  • Bid/Ask:
    3.71/3.72
  • Day's Range:
    3.65 - 3.77
Trading near 52-week Low

Australian Clinical Labs has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

1 / 2

ACL Overview

Prev. Close
3.82
Day's Range
3.65-3.77
Revenue
766.8M
Open
3.77
52 wk Range
3.65-6.39
EPS
0.886
Volume
921,024
Market Cap
747.01M
Dividend (Yield)
0.53
(14.25%)
Average Volume (3m)
1,328,004
P/E Ratio
4.74
Beta
0.831
1-Year Change
-18.95%
Shares Outstanding
200,810,300
Next Earnings Date
-
What is your sentiment on Australian Clinical Labs?
or
Market is currently closed. Voting is open during market hours.

Australian Clinical Labs Ltd Analysis

Australian Clinical Labs Ltd Company Profile

Australian Clinical Labs Ltd Company Profile

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Read More

Analyst Price Target

Average599.00 (+16002.15% Upside)
High650
Low500
Price3.72
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellSell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Sell
SummaryStrong BuyNeutralStrong SellStrong SellStrong Sell